期刊文献+

急性心肌梗死患者冠脉介入术后1年死亡风险列线图预测模型的构建 被引量:8

Establishment of a nomogram for predicting the risk of 1-year death after coronary in tervention in patients with acute myocardial infarction
下载PDF
导出
摘要 收集306例急性心肌梗死(AMI)患者的临床资料及随访1年期间死亡发生情况。原始数据按7∶3的比例随机分为建模和验证组。建模组用LASSO、Logistic回归筛选术后1年死亡的风险预测变量,构建列线图模型,验证组用受试者工作特征曲线(ROC曲线)和Hosmer-Lemeshow偏差性检验对模型进行验证。病变支数、胱抑素C及左室射血分数(LVEF)是术后1年死亡影响因素(P<0.05)。模型预测死亡风险ROC曲线下面积为0.824(0.621~1.000),Hosmer-Lemeshow偏差性检验结果χ^2=6.090(P=0.637),提示列线图模型具良好区分度及校准度,可预测急性心肌梗死患者术后1年死亡风险。 To collect the clinical data of 306 patients with acute myocardial infarction(AMI) and the occurrence of death during 1 year follow-up. The raw data were randomly divided into modeling group and validation group according to the scale of 7 ∶3. The modeling group used the least absolute shrinkage and selection operator(LASSO) regression and Logistic regression to screen the risk predictors of death at 1 year after operation to construct a nomogram model. The validation group used receiver operating characteristic curve(ROC) curve and Hosmer-Lemeshow deviation test to evaluate the prediction efficiency of the nomogram model. The number of lesions, cystatin C, and left ventricular ejection fraction(LVEF) was the influencing factors of death at 1 year after operation in patients with AMI. The area under the ROC curve of the nomogram model for predicting the risk of death was 0.824(0.621~1.000)(P<0.05), and the Hosmer-Lemeshow deviation test result was χ^2=6.090(P=0.637), suggesting that the nomogram model had good discrimination and calibration, and could be used to predict the risk of 1 year postoperative death in patients with AMI.
作者 叶青 马礼坤 张杰 Ye Qing;Ma Likun;Zhang Jie(Dept of Cardiology,Anhui Provincial Hospital Affiliated to Anhui Medical University,Hefei 230001)
出处 《安徽医科大学学报》 CAS 北大核心 2020年第12期1959-1963,共5页 Acta Universitatis Medicinalis Anhui
基金 2018年国家自然科学基金资助项目(编号:81870192)。
关键词 急性心肌梗死 冠状动脉介入术 死亡 影响因素 列线图 acute myocardial infarction coronary intervention death influencing factors nomogram
  • 相关文献

参考文献4

二级参考文献36

  • 1Barka T, van der Noen H. Expression of the eysteine proteinase inhibitor cystatin C gene in rat heart: use of digoxigenin-labeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations [J].J Histochem Cytochem, 1993,41(12) :1863-1867. 被引量:1
  • 2Filler G, Bokenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR-history, indications, and future research[J]. Clin Biochem,2005,38(1) : 1-8. 被引量:1
  • 3Shlipak MG, Katz R, Kestenbaum B, et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly[J]. Atherosclerosis, 2009,204 (1) : 298-303. 被引量:1
  • 4Ix JH,Shlipak MG,Chertow GM,et al. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease., data from the Heart and Soul Study[J].Circulation, 2007,115 (2) : 173- 179. 被引量:1
  • 5Derzhko R;Plaksej R,Przewlocka-Kosmala M,et al. Prediction of left ventricular dysfunction progression in patients with a first ST-elevation myocardial infarction-contribution of cystatin C assessment[J].Coron Artery Dis,2009,20(7):453-461. 被引量:1
  • 6Kilic T, Oner G, Ural E, et al. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome [J]. Atherosclerosis, 2009,207 (2) : 552-558. 被引量:1
  • 7Garcia Acuna JM, Gonzalez-Babarro E, Grigorian Shamagian L, et al. Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome[J]. Rev Esp Cardiol,2009,62(5) :510-519. 被引量:1
  • 8Windhausen F, Hirsch A, Fischer J, et al. Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T[J]. Clin Chem,2009,55(6) :1118-1125. 被引量:1
  • 9Kiyosue A, Hirata Y, Ando J, et al. Plasma eystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease[J]. Circ J, 2010, 74 (11):2441-2447. 被引量:1
  • 10Shlipak M.G,Katz R,Fried L F,et al.Cystatin-C and mortality in elderly persons with heart failure. Journal of the American College of Cardiology . 2005 被引量:1

共引文献52

同被引文献84

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部